1GEORGE JN, WOOLF SH, RASKOB GE, et al. Idiopathic thromhocytopenic purpura :a practice guideline developed by explicit methods for the American Society of Hematology [J].Blood,1996,88:3-40.
2GOLDMAN SC, BRACHO F, DAVENPORT V,et al. Fensibility of IL-11 and granulocyte colony stimulating factor after myelosuppresive chemotherapy to mobilize peripheral blood stem cells from heavily pretreated patients [J]. J Pediatr Hematoloncol, 2001, 23 (5):300-305.
3DU X, WILLIAMS DA. Interleukin-11:review of molecular, cell biology and clinical use[J].Blood, 1997, 89:3897-3908.
4SAITOH M, TAGUCHI K, MOMOSE K, et al. Recombinant human interleukin-ll improved carboplatin induced thrombocytopenia without affecting antitum or activities in mice bearing lewis lung carcinoma cells [J]. Cancer Chemother Pharmacol, 2002, 49 (2): 161-166.
3Schiffer CA,Anderson KC,Bennett CL,et al.Platelet transfusion for patients with cancer:clinical practice guidelines of the American Society of Clinical Oncology.J Clin Oncol,2001,19:1519-1538.
4Kaushansky K.Use of thrombopoietic growth factors in acute leukemia.Leukemia,2000,14:505-508.
5Keller DC,Du XX,Srour EF,et al.Interleukin-11 inhibits adipogenesis and stimulates myelopoiesis in human long-term marrow cultures.Blood,1993,82:1428-1435.
6Tsimberidou AM,Giles FJ,Khouri I,et al.Low-dose interleukin11 in patients with bone marrow failure:update of the M.D.Anderson Cancer Center experience.Ann Oncol,2005,16:139-145.
8Xu J,Ren JF,Mugelli A,et al.Age-dependent atrial re modeling induced by recombinant human interleukin-11:implications for atrial flutter/fibrillation.J Cardiovasc Pharmacol,2002,39:435-440.
